AndrewSRhinehartMDFACP,FACE,CDE,
Internal Medicine • Northridge, CASenior Medical Director at Medtronic Diabetes
Dr. Rhinehart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18000 Devonshire Street
Northridge, CA 91325Phone+1 276-614-8396
Education & Training
East Tennessee State University/Quillen College of MedicineResidency, Internal Medicine, 1992 - 1995
University of Maryland School of MedicineClass of 1992
Juniata CollegeB.S., Pre-Medicine Biology, Cum Laude, 1984 - 1988- East Tennessee State University/Quillen College of MedicineChief Residency, Internal Medicine
Certifications & Licensure
CA State Medical License 2020 - 2026
FL State Medical License 2016 - 2022
VA State Medical License 1995 - 2020
TN State Medical License 1993 - 2016- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Certified Diabetes Educator
- Board Certified-Advanced Diabetes Management American Association of Diabetes Educators
- Certified Diabetese Technology Clinician Diabetes Technology Society
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsImproved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.Satish K Garg, George Grunberger, Ruth Weinstock, Margaret L Lawson, Irl B Hirsch
Diabetes Technology & Therapeutics. 2023-01-01 - 14 citationsEvaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial.Ron Brazg, Satish K Garg, Anuj Bhargava, James R Thrasher, Kashif Latif
Diabetes Technology & Therapeutics. 2022-08-01 - 113 citationsSafety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.Anders L. Carlson, Jennifer L. Sherr, Dorothy I. Shulman, Satish K. Garg, Rodica Pop-Busui
Diabetes Technology & Therapeutics. 2021-11-16
Press Mentions
Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert with CGM, Smart Pens and Other Diabetes TechnologiesMay 16th, 2019- Glytec Adds Smart Meter to Growing Network of Connected Solution PartnersJune 6th, 2018
News 8/2/17August 1st, 2017
Committees
- Member, American Diabetes Association Primary Care Advisory Group 2012 - Present
- Member, American Diabetes Association Prevention Committee 2013 - 2014
- Chair, American Diabetes Association Primary Care Advisory Group 2013 - 2014
- Member, American Diabetes Association Professional Practice Committee 2011 - 2012
- Member, Revision Workgroup for National Standards of Diabetes Self Management Education 2011 - 2012
Professional Memberships
- Fellow
- Fellow
- Member
Industry Relationships
- Senior Medical Director, Medtronic Diabetes2020 - Present
- Chief Medical Officer, Glytec2015 - 2019
- Consultant, Boehringer Ingelheim2014 - 2015
- Speakers' Bureau, Astra Zeneca2013 - 2015
- Advisory Board, Janssen2013 - 2015
- Speakers Bureau, Janssen2013 - 2015
- Advisory Board, Sanofi2012 - 2015
- Speakers Bureau, Sanofi2011 - 2015
- Speakers Bureau, Boehringer Ingelheim2011 - 2015
- Consultant, Sanofi2011 - 2015
- Speakers Bureau, Lilly2010 - 2015
- Speakers Bureau, Novo Nordisk2009 - 2015
- Speakers Bureau, BMS2012 - 2014
- Speakers Bureau, Forest2011 - 2014
- Speakers Bureau, Abbott2010 - 2012
External Links
- LinkedInhttps://www.linkedin.com/in/andrewsrhinehartmd/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
